These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24936585)

  • 1. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.
    Greven DE; Cohen ES; Gerlag DM; Campbell J; Woods J; Davis N; van Nieuwenhuijze A; Lewis A; Heasmen S; McCourt M; Corkill D; Dodd A; Elvin J; Statache G; Wicks IP; Anderson IK; Nash A; Sleeman MA; Tak PP
    Ann Rheum Dis; 2015 Oct; 74(10):1924-30. PubMed ID: 24936585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.
    Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA
    Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
    Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
    Front Immunol; 2020; 11():613975. PubMed ID: 33679701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary pharmacodynamics of an anti-GM-CSFRα antibody enables therapeutic dosing that limits exposure in the lung.
    Campbell J; Nys J; Eghobamien L; Cohen ES; Robinson MJ; Sleeman MA
    MAbs; 2016 Oct; 8(7):1398-1406. PubMed ID: 27560702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
    Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
    Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
    Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting GM-CSF in rheumatoid arthritis.
    Avci AB; Feist E; Burmester GR
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):39-44. PubMed ID: 27586802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of granulocyte macrophage-colony stimulating factor and its receptor in the synovium of osteoarthritis patients is negatively correlated with pain.
    van Helvoort EM; Eijkelkamp N; Lafeber FPJG; Mastbergen SC
    Rheumatology (Oxford); 2020 Nov; 59(11):3452-3457. PubMed ID: 32365364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
    van Baarsen LG; Lebre MC; van der Coelen D; Aarrass S; Tang MW; Ramwadhdoebe TH; Gerlag DM; Tak PP
    Arthritis Res Ther; 2014 Aug; 16(4):426. PubMed ID: 25146432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
    Guo X; Higgs BW; Bay-Jensen AC; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Rheumatology (Oxford); 2018 Jan; 57(1):175-184. PubMed ID: 29069507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil GM-CSF receptor dynamics in acute lung injury.
    De Alessandris S; Ferguson GJ; Dodd AJ; Juss JK; Devaprasad A; Piper S; Wyatt O; Killick H; Corkill DJ; Cohen ES; Pandit A; Radstake TRDJ; Simmonds R; Condliffe AM; Sleeman MA; Cowburn AS; Finch DK; Chilvers ER
    J Leukoc Biol; 2019 Jun; 105(6):1183-1194. PubMed ID: 30942918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis.
    Alivernini S; Bruno D; Tolusso B; Bui L; Petricca L; Gigante MR; Birra D; Fedele AL; Peluso G; Federico F; Ferraccioli G; Gremese E
    Arthritis Res Ther; 2019 May; 21(1):116. PubMed ID: 31072400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study.
    Burmester GR; Feist E; Sleeman MA; Wang B; White B; Magrini F
    Ann Rheum Dis; 2011 Sep; 70(9):1542-9. PubMed ID: 21613310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
    Cook AD; Braine EL; Campbell IK; Rich MJ; Hamilton JA
    Arthritis Res; 2001; 3(5):293-8. PubMed ID: 11549370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cy3-tilmanocept labeling of macrophages in joints of mice with antibody-induced arthritis and synovium of human patients with rheumatoid arthritis.
    Toribio RE; Young N; Schlesinger LS; Cope FO; Ralph DA; Jarjour W; Rosol TJ
    J Orthop Res; 2021 Apr; 39(4):821-830. PubMed ID: 33107629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha.
    Alvaro-Gracia JM; Zvaifler NJ; Brown CB; Kaushansky K; Firestein GS
    J Immunol; 1991 May; 146(10):3365-71. PubMed ID: 2026869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and binding kinetics of a soluble granulocyte-macrophage colony-stimulating factor receptor alpha-chain-Fc fusion protein.
    Monfardini C; Ramamoorthy M; Rosenbaum H; Fang Q; Godillot PA; Canziani G; Chaiken IM; Williams WV
    J Biol Chem; 1998 Mar; 273(13):7657-67. PubMed ID: 9516471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors.
    Ballanti E; Perricone C; di Muzio G; Kroegler B; Chimenti MS; Graceffa D; Perricone R
    Autoimmun Rev; 2011 Aug; 10(10):617-23. PubMed ID: 21549221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.